Proven Fatal Invasive Aspergillosis in a Patient with COVID-19 and Staphylococcus aureus Pneumonia

Frank van Someren Gréve1, Romy du Long2, Raju Talwar3

  • 1Department of Medical Microbiology, Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands.

Insights

Opportunistic fungal infections like Aspergillus fumigatus are a concern in severe COVID-19. This case confirms COVID-19-associated pulmonary aspergillosis via post-mortem lung biopsy culture.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Rising incidence of opportunistic fungal infections complicating severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in critically ill patients.
  • Challenges in diagnosing invasive fungal diseases due to the need for invasive procedures for definitive diagnosis.

Observation:

  • A critically ill patient with SARS-CoV-2 infection developed complications.
  • Diagnostic procedures for invasive fungal disease can be invasive and challenging.

Findings:

  • This report details one of the first proven cases of COVID-19-associated pulmonary aspergillosis.
  • Diagnosis was confirmed by positive culture of *Aspergillus fumigatus* from a post-mortem lung biopsy.

Implications:

  • Highlights the importance of considering invasive aspergillosis in SARS-CoV-2 patients.
  • Post-mortem lung biopsy is a valuable tool for confirming invasive pulmonary aspergillosis in complex cases.
  • Underscores the diagnostic challenges and potential severity of co-infections in critically ill COVID-19 patients.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
451
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
566
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
467
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
627